how does a glp 1 agonist work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: Scoping Review Is GLP-1 Safe for Weight

32 Included patients were matched for age, sex, race and ethnicity, cardiovascular diseases, DR severity (including PDR and DME status), history of tobacco use, body mass index, and hemoglobin A1c percentage

Nonetheless, further data are needed to assess the safety of retatrutide on muscle mass, particularly in populations at risk for sarcopenia, where caution is warranted

Acknowledgements I would like to thank my former PhD students and post-docs Anne Raben, Anne Flint, Camilla Verdich, Birgitte Sloth, Helle Harder, Anita Belza and Thomas Meinert Larsen for their invaluable contributions to the research described in this article

It is important to avoid injecting lixisenatide after a meal or in case of a missed meal

For raw weight loss, the data so far puts retatrutide out ahead of Ozempic, 24.2 percent at 12 mg over 48 weeks versus 14.9 percent at 2.4 mg over 68 weeks for semaglutide